Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

207 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
STAR SIGN study: Evaluation of COVID-19 vaccine efficacy against the SARS-CoV-2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel disease.
Woelfel S, Dütschler J, König M, Dulovic A, Graf N, Junker D, Oikonomou V, Krieger C, Truniger S, Franke A, Eckhold A, Forsch K, Koller S, Wyss J, Krupka N, Oberholzer M, Frei N, Geissler N, Schaub P; STAR SIGN Study Investigators; Albrich WC, Friedrich M, Schneiderhan-Marra N, Misselwitz B, Korte W, Bürgi JJ, Brand S. Woelfel S, et al. Among authors: krieger c. Aliment Pharmacol Ther. 2023 Oct;58(7):678-691. doi: 10.1111/apt.17661. Epub 2023 Aug 12. Aliment Pharmacol Ther. 2023. PMID: 37571863
Systemic and T cell-associated responses to SARS-CoV-2 immunisation in gut inflammation (STAR SIGN study): effects of biologics on vaccination efficacy of the third dose of mRNA vaccines against SARS-CoV-2.
Woelfel S, Dütschler J, König M, Graf N, Oikonomou V, Krieger C, Truniger S, Franke A, Eckhold A, Forsch K, Wyss J, Krupka N, Albrich W, Frei N, Geissler N, Schaub P; STAR SIGN Study Investigators; Friedrich M, Misselwitz B, Korte W, Bürgi JJ, Brand S. Woelfel S, et al. Among authors: krieger c. Aliment Pharmacol Ther. 2023 Jan;57(1):103-116. doi: 10.1111/apt.17264. Epub 2022 Oct 28. Aliment Pharmacol Ther. 2023. PMID: 36307899 Free PMC article.
Fatigue in inflammatory bowel disease and its impact on daily activities.
Schreiner P, Rossel JB, Biedermann L, Valko PO, Baumann CR, Greuter T, Scharl M, Vavricka SR, Pittet V, Juillerat P, Rogler G, von Känel R, Misselwitz B; Swiss IBD Cohort Study Group. Schreiner P, et al. Aliment Pharmacol Ther. 2021 Jan;53(1):138-149. doi: 10.1111/apt.16145. Epub 2020 Nov 7. Aliment Pharmacol Ther. 2021. PMID: 33159475
Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease.
Serra EG, Schwerd T, Moutsianas L, Cavounidis A, Fachal L, Pandey S, Kammermeier J, Croft NM, Posovszky C, Rodrigues A, Russell RK, Barakat F, Auth MKH, Heuschkel R, Zilbauer M, Fyderek K, Braegger C, Travis SP, Satsangi J, Parkes M, Thapar N, Ferry H, Matte JC, Gilmour KC, Wedrychowicz A, Sullivan P, Moore C, Sambrook J, Ouwehand W, Roberts D, Danesh J, Baeumler TA, Fulga TA, Carrami EM, Ahmed A, Wilson R, Barrett JC, Elkadri A, Griffiths AM; COLORS in IBD group investigators; Oxford IBD cohort study investigators; INTERVAL Study; Swiss IBD cohort investigators; UK IBD Genetics Consortium; NIDDK IBD Genetics Consortium; Snapper SB, Shah N, Muise AM, Wilson DC, Uhlig HH, Anderson CA. Serra EG, et al. Nat Commun. 2020 Feb 21;11(1):995. doi: 10.1038/s41467-019-14275-y. Nat Commun. 2020. PMID: 32081864 Free PMC article.
New Upper Limit on the Axion-Photon Coupling with an Extended CAST Run with a Xe-Based Micromegas Detector.
Altenmüller K, Anastassopoulos V, Arguedas-Cuendis S, Aune S, Baier J, Barth K, Bräuninger H, Cantatore G, Caspers F, Castel JF, Çetin SA, Christensen F, Cogollos C, Dafni T, Davenport M, Decker TA, Desch K, Díez-Ibáñez D, Döbrich B, Ferrer-Ribas E, Fischer H, Funk W, Galán J, García JA, Gardikiotis A, Giomataris I, Golm J, Hailey CH, Hasinoff MD, Hoffmann DHH, Irastorza IG, Jacoby J, Jakobsen AC, Jakovčić K, Kaminski J, Karuza M, Kostoglou S, Krieger C, Lakić B, Laurent JM, Luzón G, Malbrunot C, Margalejo C, Maroudas M, Miceli L, Mirallas H, Navarro P, Obis L, Özbey A, Özbozduman K, Papaevangelou T, Pérez O, Pivovaroff MJ, Rosu M, Ruiz-Chóliz E, Ruz J, Schmidt S, Schumann M, Semertzidis YK, Solanki SK, Stewart L, Vafeiadis T, Vogel JK, Zioutas K; CAST Collaboration. Altenmüller K, et al. Among authors: krieger c. Phys Rev Lett. 2024 Nov 29;133(22):221005. doi: 10.1103/PhysRevLett.133.221005. Phys Rev Lett. 2024. PMID: 39672143
STAR LIGHT Study: XBB.1.5 COVID-19 mRNA Vaccines Boost Systemic but Not Mucosal Immunity Against the SARS-CoV-2 JN.1 Variant in Patients with Chronic Liver Disease.
Woelfel S, Junker D, Bergamin I, Meyer-Herbon P, Stillhard R, Graf N, Leinenkugel G, Dütschler J, König M, Kammerlander L, Häuptle R, Zwyssig S, Krieger C, Truniger S, Koller S, Metzger-Peter K, Frei N, Star Sign Study Investigators, Albrich WC, Friedrich M, Bernsmeier C, Niess JH, Korte W, Bürgi JJ, Dulovic A, Schneiderhan-Marra N, Semela D, Brand S. Woelfel S, et al. Among authors: krieger c. Vaccines (Basel). 2024 Oct 31;12(11):1241. doi: 10.3390/vaccines12111241. Vaccines (Basel). 2024. PMID: 39591144 Free PMC article.
XBB.1.5-Adapted COVID-19 mRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS-CoV-2 JN.1 Variant in Patients With Inflammatory Bowel Disease.
Woelfel S, Dütschler J, Junker D, König M, Graf N, Krieger C, Truniger S, Oikonomou V, Leinenkugel G, Koller S, Metzger-Peter K, Wyss J, Krupka N, Frei N; STAR SIGN Study Investigators; Albrich WC, Friedrich M, Niess JH, Schneiderhan-Marra N, Dulovic A, Misselwitz B, Korte W, Bürgi JJ, Brand S. Woelfel S, et al. Among authors: krieger c. Aliment Pharmacol Ther. 2025 Jan;61(2):299-312. doi: 10.1111/apt.18349. Epub 2024 Oct 29. Aliment Pharmacol Ther. 2025. PMID: 39468971
Systemic and Mucosal Immunogenicity of Monovalent XBB.1.5-Adapted COVID-19 mRNA Vaccines in Patients with Inflammatory Bowel Disease.
Woelfel S, Dütschler J, Junker D, König M, Leinenkugel G, Graf N, Krieger C, Truniger S, Franke A, Koller S, Metzger-Peter K, Oberholzer M, Frei N, Geissler N, Schaub P, Star Sign Investigators, Albrich WC, Friedrich M, Niess JH, Schneiderhan-Marra N, Dulovic A, Korte W, Bürgi JJ, Brand S. Woelfel S, et al. Among authors: krieger c. Vaccines (Basel). 2024 Jul 15;12(7):774. doi: 10.3390/vaccines12070774. Vaccines (Basel). 2024. PMID: 39066413 Free PMC article.
207 results